Skip to main content
. 2021 Mar 30;204(1):34–43. doi: 10.1164/rccm.202011-4166OC

Figure 1.

Figure 1.

Age-specific cumulative incidence of extracorporeal membrane oxygenation (ECMO) use per population of 100,000 and 90-day mortality for (A) patients receiving ECMO support and (B) daily patients on ECMO during the first wave of the coronavirus disease (COVID-19) pandemic in Chile. The incidence (black dots), cumulative incidence of ECMO use (solid line), mortality risk (black crosses), and age-specific 90-day mortality risk (dashed line) for patients receiving ECMO support are shown.